Linde M. van Veenendaal

The genomic landscape of 85 advanced neuroendocrine neoplasms reveals subtype-heterogeneity and potential therapeutic targets

Job van Riet, Harmen J.G. van de Werken, Edwin Cuppen et al. · Nature Communications · 2021 · 117 citations · Full text

Merkel cell carcinoma: Clinical outcome and prognostic factors in 351 patients

Linde M. van Veenendaal, Alexander C. J. van Akkooi, Cees Verhoef et al. · Journal of Surgical Oncology · 2018 · 44 citations

The Clinical Utility of Neuron-Specific Enolase (NSE) Serum Levels as a Biomarker for Merkel Cell Carcinoma (MCC)

Linde M. van Veenendaal, Eduardo Bertolli, Catharina M. Korse et al. · Annals of Surgical Oncology · 2020 · 25 citations

Neuron-specific Enolase, Biomarker (Medicine), Medicine +9

Molecular prognostic factors in small-intestinal neuroendocrine tumours

Kris G. Samsom, Linde M. van Veenendaal, Gerlof D. Valk et al. · Endocrine Connections · 2019 · 23 citations · Full text

Driver mutations occur frequently in metastases of well‐differentiated small intestine neuroendocrine tumours

Kris G. Samsom, Sonja Levy, Linde M. van Veenendaal et al. · Histopathology · 2020 · 18 citations